ArticleTherapeutic advances in gastroenterology2020

Safety of vedolizumab in the treatment of pregnant women with inflammatory bowel disease: a targeted literature review.

Birgit Terjung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.